omniture
南京驯鹿医疗技术有限公司

Latest News

IASO Biotheraputics' CT120 Granted Orphan Drug Designation by the U.S. FDA

SAN JOSE, Calif., NANJING, China and SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- IASO Biotherapeutics (...

2021-11-26 11:05 2421

IASO Biotherapeutics and Innovent Biologics to Present New BCMA CAR-T Cell Therapy Data in Oral Presentation at ASH 2021

SAN JOSE, Calif., NANJING, China and SHANGHAI, Nov. 10, 2021 /PRNewswire/ -- IASO Biotherapeutics("...

2021-11-10 21:30 2238

IASO Biotheraputics Completes Enrollment of First Patient in CT120's Phase I/II Registrational Clinical Trial

SAN JOSE, Calif. and SHANGHAI and NANJING, China, Nov. 9, 2021 /PRNewswire/ --  IASO Biotherapeutics...

2021-11-09 21:30 1736
123